These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30806860)

  • 1. Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.
    Watanabe Y; Miyoshi N; Fujino S; Takahashi H; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Doki Y; Mori M; Mizushima T
    Dig Dis Sci; 2019 Aug; 64(8):2280-2285. PubMed ID: 30806860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study.
    Elriz K; Palascak-Juif V; Joly F; Seguy D; Beau P; Chambrier C; Boncompain M; Fontaine E; Laharie D; Savoye G; Lerebours E
    Aliment Pharmacol Ther; 2011 Oct; 34(8):931-40. PubMed ID: 21848855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and Prognosis of Intestinal Failure in Crohn's Disease: An 18-year Experience From a National Centre.
    Soop M; Khan H; Nixon E; Teubner A; Abraham A; Carlson G; Lal S
    J Crohns Colitis; 2020 Nov; 14(11):1558-1564. PubMed ID: 32215559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of intestinal failure in Crohn's disease.
    Agwunobi AO; Carlson GL; Anderson ID; Irving MH; Scott NA
    Dis Colon Rectum; 2001 Dec; 44(12):1834-7. PubMed ID: 11742170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for urolithiasis in patients with Crohn's disease.
    Miyajima S; Ishii T; Watanabe M; Ueki T; Tanaka M
    Int J Urol; 2021 Feb; 28(2):220-224. PubMed ID: 33191551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
    Riss S; Schuster I; Papay P; Mittlböck M; Stift A
    Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type.
    Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T
    J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of pediatric Crohn's disease in Belgium.
    De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
    J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term course of Crohn's disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery.
    Sato Y; Matsui T; Yano Y; Tsurumi K; Okado Y; Matsushima Y; Koga A; Takahashi H; Ninomiya K; Ono Y; Takatsu N; Beppu T; Nagahama T; Hisabe T; Takaki Y; Hirai F; Yao K; Higashi D; Futami K; Washio M
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1713-9. PubMed ID: 26094852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
    Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
    Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
    Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and frequent histological recurrence of Crohn's disease in small intestinal allografts.
    Harpaz N; Schiano T; Ruf AE; Shukla D; Tao Y; Fishbein TM; Sauter BV; Gondolesi GE
    Transplantation; 2005 Dec; 80(12):1667-70. PubMed ID: 16378058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease.
    Freeman HJ; Freeman KJ
    Can J Gastroenterol; 2000 Feb; 14(2):138-43. PubMed ID: 10694287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
    Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
    J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of Crohn's disease: indications, results and predictive factors of recurrence and morbidity.
    Hefaiedh R; Sabbeh M; Miloudi N; Ennaifer R; Romdhane H; Belhadj N; Gharbi L; Khalfallah T
    Tunis Med; 2015 Jun; 93(6):356-60. PubMed ID: 26644097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with perianal Crohn's fistulas experience delays in accessing anti-TNF therapy due to slow recognition, diagnosis and integration of specialist services: lessons learned from three referral centres.
    Lee MJ; Freer C; Adegbola S; Elkady S; Parkes M; Hart A; Fearnhead NS; Lobo AJ; Brown SR
    Colorectal Dis; 2018 Sep; 20(9):797-803. PubMed ID: 29569419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk score system to timely manage treatment in Crohn's disease: a cohort study.
    Pallotta N; Vincoli G; Pezzotti P; Giovannone M; Gigliozzi A; Badiali D; Vernia P; Corazziari ES
    BMC Gastroenterol; 2018 Nov; 18(1):164. PubMed ID: 30400823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.